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Background: Cardiac inflammation and apoptosis contribute to doxorubicin (DOX)-induced cardiomyopathy. Since NF-gB participates in 
inflammatory response and apoptosis, we investigated whether NF-gB is involved in DOX-induced cardiotoxicity.
Methods: A transgenic (Tg) mouse model of cardiac-specific inhibition of NF-gB was used. Age-matched wild-type (WT), nontransgenic littermates 
(NTg) and IgB-_Tg mice received vehicle or DOX (7.5 mg/kg i.p. 2 times over 2 wks), and were divided into 6 groups: group I (WT, vehicle); 
group II (NTg, vehicle); group III (Tg, vehicle); group IV (WT, DOX); group V (NTg, DOX); and group VI (Tg, DOX). Cardiac function was assessed by 
echocardiography and hemodynamics. Mice were euthanized 2 wks after the first DOX. The LV tissue was harvested for myocardial protein expression 
of proinflammatory cytokines (TNF-_, IL6) and proapopotic markers (Bax, p53).
Results: Compared with WT and NTg mice, survival was greater in Tg mice at 2 wks after DOX (43% and 43% vs. 73%, in groups IV-VI, respectively, 
p<0.05). After 2 wks, compared with group IV and group V, group VI exhibited improved LV EF, LV pressures, ±dP/dt, LV diameters, and LV end-
diastolic volume. Hearts from Tg mice also showed a significant decrease in inflammation and apoptosis, as indicated by reduced protein expression 
for TNF-_, IL6, and Bax (Figure).
Conclusions: Inhibition of NF-gB protects against adverse consequences of DOX. This novel approach may be useful to prevent cardiomyopathy in 
DOX-treated cancer patients.
